In addition, under sympathetic stimulation, osteoblast derived vascular endothelial growth factor (VEGF) and IL-1β was able to modulate endothelial cells to facilitate breast cancer cell extravasation from circulation into the bone marrow niche, both in vitro and in vivo [18,22]. The gene discussed is IL1B; the disease is breast cancer.